Jean-Éric Tarride is the Director of CHEPA. He is an Associate Professor in McMaster's Department of Health Research Methods, Evidence, and Impact (HEI) and co-director of the Programs for Assessment of Technology in Health (PATH) Research Institute, which consists of multiple research programs in economic evaluation and health technology assessment (HTA). He is the faculty director of the Trial & Economic Modeling Methodology Program (TEMMP) at PATH. Tarride is also an Associate Member of the Department of Economics at McMaster and a Faculty Member of the Centre for Evaluation of Medicines (CEM), St. Josephs Healthcare, Hamilton.
He has a PhD in Economics from Concordia University (2004), an M.A. in Labour Economics (Toulouse, 1991) and an Honours B.A. in Econometrics (Toulouse, 1989). Tarride received a 2007 Career Scientist Award from the Ontario Ministry of Health and Long-Term Care (MOHLTC). His primary research interests are in methods for the economic evaluation of health technologies and treatment of uncertainty in health technology assessments. He has authored more than 100 peer-reviewed journal articles related to economic evaluations of healthcare technologies. Tarride has also worked for more than 10 years in the pharmaceutical industry including as Director of Health Economics and Reimbursement at AstraZeneca Canada.
- Methods for the economic evaluation of health technologies
- Treatment of uncertainty in health technology assessments
Lee JY, Muratov S, Tarride J-E, Holbrook AM. Managing high-cost healthcare users: The international search for effective evidence-supported strategies. Journal of the American Geriatrics Society. Feb 10.2018.
Tarride JE, Hopkins RB, Burke N, Guertin J, Fell C, Dion G, Kolb M. Economic burden of illness of idiopathic pulmonary fibrosis in Quebec Canada: a 7-year retrospective study. ClinicoEconomics and Outcomes Research. 2017. Forthcoming.
Tarride J-E, Smofsky A, Nykoliation P, AllainS, Lewis-DalyL, Sotak D, Schwartz J, Hart Pollack J, GuertinJR, McIntyreR. Effectiveness of a type 2 diabetes screening intervention in the Canadian workplace. Canadian Journal of Diabetes. 2017.
Tarride JE, Hopkinbs RB, Blackhouse G, Burke N, Bhandari M, Johal H, Guyatt GH, Busse JW. Low-intensity pulsed ultrasound for treatment of tibial fractures: an economic evaluation of the TRUST study. The Bone & Joint Journal. 2017 Nov; doi: 10.1302/0301-62X.99B11.BJJ-2017-0737.
Tarride J-E, Breau R, Sharma A, Hong D, Gmora S, Guertin JR, O’Reilly D, Xie F, Anvari M. The effect of bariatric surgery on mobility, health-related quality of life, healthcare resource utilization and employment status. Obesity Surgery. 2016. Aug 8; doi.org/10.1007/s11695-016-2298-6.
Tarride JE, Burke N, Von Keyserlingk C, O'Reilly D, Xie F, Goeree R. Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents. Clinicoeconomics Outcomes Research. 2012.4:287-98.
Tarride JE, Lim ME, Bowen JM, McCarron CE, Blackhouse G, Hopkins R, O'Reilly D, Xie F, Goeree R. In search of the evidentiary foundation of published Canadian economic evaluations (2001-06). International Journal of Technology Assessment in Health Care 2009. 25(2): 214-221.
- principles and components of contemporary health technology assessment
- costing methodology for economic evaluations
- techniques of decision analytic modelling